Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Microvascular Research|June 20, 2013
Role of HDL in neutralizing the VLDL effect on endothelial dysfunctionValeria Zago, Susana Gorzalczany, Diego Lucero, et al.
Endocrinology and Metabolism Clinics of North America|August 13, 2022
Lipoprotein Assessment in the twenty-first CenturyDiego Lucero, Anna Wolska, Zahra Aligabi, et al.
European Journal of Clinical Investigation|August 23, 2014
Adiponectin predicts MMP-2 activity independently of obesityVerónica Miksztowicz, Nahuel Fernandez Machulsky, Diego Lucero, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 19, 2020
Potentiometric CheqSol and standardized shake-flask solubility methods are complimentary tools in physicochemical profilingDiego Lucero-Borja, Xavier Subirats, Rafael Barbas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 25, 2014
Role of SN1 lipases on plasma lipids in metabolic syndrome and obesityVerónica Miksztowicz, Laura Schreier, Mary McCoy, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 23, 2015
Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-αDiego Lucero, Verónica Miksztowicz, Vanesa Macri, et al.
Clinical Biochemistry|January 17, 2012
Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatographyDiego Lucero, Valeria Zago, Gustavo H López, et al.
Clinical Biochemistry|May 22, 2016
Alterations in triglyceride rich lipoproteins are related to endothelial dysfunction in metabolic syndromeDiego Lucero, Graciela I López, Susana Gorzalczany, et al.
Atherosclerosis|August 2, 2015
Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCATDiego Lucero, Denis Sviridov, Denis Svidirov, et al.
Pageof 3